This study preliminarily explored the role of miR-200a-3p in endometrial cancer and demonstrated its regulatory role in the EMT process, including ZEB1 expression, which can provide a promising target for treating metastatic endometrial cancer. The gene discussed is ZEB1; the disease is endometrial cancer.